# Semaglutide and tirzepatide: Oral cavity effects of weight-loss therapies

**Authors:** Maria Eduarda Bernardo, Felipe Gomes Dallepiane, Mario Escobar, Ariadne Cristiane Cabral Cruz, Cesar Augusto Magalhães Benfatti

PMC · DOI: 10.17179/excli2025-9065 · EXCLI Journal · 2026-01-09

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, GIP (gastric inhibitory polypeptide) [NCBI Gene 2695]
- **Diseases:** Ozempic breath (MESH:D004417), mucosal inflammation (MESH:D007249), reflux (MESH:D005764), loss (MESH:D016388), dysgeusia (MESH:D004408), halitosis (MESH:D006209), metabolic disorders (MESH:D008659), Ozempic tongue (MESH:D014060), vomiting (MESH:D014839), oral diseases (MESH:D009059), diarrhea (MESH:D003967), infections (MESH:D007239), Gastrointestinal disturbances (MESH:D005767), weight (MESH:D015431), dental erosion (MESH:D014077), dentin hypersensitivity (MESH:D003807), dental caries (MESH:D003731), hypertension (MESH:D006973), atherosclerotic (MESH:D050197), nausea, vomiting (MESH:D020250), Xerostomia (MESH:D014987), type 2 diabetes mellitus (MESH:D003924), candidiasis (MESH:D002177), hypersensitivity (MESH:D004342), decreased appetite (MESH:D001068)
- **Chemicals:** fluoride (MESH:D005459), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946442/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946442/full.md

---
Source: https://tomesphere.com/paper/PMC12946442